Responses
Nursing issues
Randomised controlled trial
Aspirin given for up to 2 years after initial anticoagulant treatment reduces the risk of venous thromboembolism recurrence without increasing risk of major bleeding
Compose a Response to This Article
Other responses
No responses have been published for this article.